Skip to main content
    S

    Solesence, Inc. Common Stock (SLSN)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ

    $1.60
    +0.08 (+5.26%)

    Market Cap: $107.38M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Solesence, Inc. Common Stock (SLSN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Solesence, Inc. Common Stock reported revenue of $62.06M for the fiscal year ended Dec 31, 2025, up 18.6% from the year before. That year, net income was $2.81M with a net margin of 4.5%, operating cash flow was -$8.57M and free cash flow was -$10.71M. The quarter ended Sep 30, 2026 had revenue of $20.16M and net income of $3.67M.

    Revenue and Margins

    The operating margin was 4.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $10.78M, a compound annual rate of 21.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$62.06M+18.6%27.5%4.2%4.5%
    Dec 2024$52.35M+40.4%24.9%3.8%2.1%
    Dec 2023$37.30M-0.1%19.5%-11.0%-13.2%
    Dec 2022$37.32M+26.6%22.4%-6.1%-7.0%
    Dec 2021$29.48M+72.1%29.5%8.7%7.9%
    Dec 2020$17.12M+36.9%35.0%8.7%5.8%
    Dec 2019$12.51M-11.9%20.9%-22.4%-24.0%
    Dec 2018$14.19M-18.0%23.2%-14.3%-14.7%
    Dec 2017$17.32M+60.6%22.2%-4.5%-4.6%
    Dec 2016$10.78MN/A30.0%-11.8%-11.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 155.5% from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$62.06M$52.35M$37.30M$37.32M$29.48M$17.12M$12.51M$14.19M$17.32M$10.78M
    Cost of revenue$44.98M$39.30M$30.02M$28.96M$20.79M$11.13M$9.89M$10.90M$8.62M$7.54M
    Gross profit$17.08M$13.05M$7.28M$8.36M$8.69M$5.99M$2.62M$3.29M$3.85M$3.24M
    Research and development$4.09M$3.84M$3.84M$3.04M$2.23M$1.57M$1.87M$2.06M$1.74M$1.55M
    Operating income$2.59M$2.00M-$4.09M-$2.26M$2.56M$1.49M-$2.80M-$2.02M-$772.00K-$1.27M
    Net income$2.81M$1.10M-$4.94M-$2.62M$2.32M$989.00K-$3.01M-$2.08M-$789.00K-$1.28M
    EBITDA$4.71M$2.92M-$3.35M-$1.69M$4.87M$2.11M-$2.45M-$1.70M-$411.00K-$658.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$20.16M$15.33M$12.96M$12.48M$14.60M$20.36M$14.63M$12.57M$16.87M$13.05M$9.87M$8.01M
    Gross profit$7.93M$4.65M$3.17M$3.43M$3.47M$6.53M$3.53M$2.77M$5.78M$3.74M$3.58M$471.00K
    Operating income$4.04M$23.00K-$674.00K$187.00K-$677.00K$2.56M$407.00K-$224.00K$2.87M$1.05M$1.11M-$1.90M
    Net income$3.67M-$256.00K-$936.00K$163.00K-$1.02M$3.32M$231.00K-$559.00K$2.72M$856.00K$893.00K-$2.13M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $11.76M exceeded cash and equivalents by $10.47M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$46.42M$45.35M$31.37M$33.56M$28.39M$13.54M$9.37M$6.57M$6.27M$4.84M
    Current assets$25.14M$24.70M$14.79M$16.63M$11.60M$8.84M$4.99M$4.69M$4.62M$3.43M
    Cash and equivalents$1.29M$1.41M$1.72M$2.19M$657.00K$957.00K$1.19M$1.34M$1.96M$1.78M
    Total liabilities$32.42M$35.06M$30.98M$27.91M$20.93M$10.81M$7.86M$5.18M$3.03M$2.05M
    Short-term debt$1.25M$2.26M$4.81M$4.28M$1.35M$1.00M$1.00M$218.00K$443.00K$107.00K
    Long-term debt$10.50M$0$6.00M$4.00M$1.00M$952.00K$0N/AN/AN/A
    Shareholder equity$14.00M$10.29M$387.00K$5.65M$7.46M$2.73M$1.51M$1.38M$3.23M$2.79M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$44.44M$46.28M$43.99M$50.05M$50.24M$59.96M$57.02M$50.00M$48.05M$40.85M$38.50M$32.88M
    Total liabilities$27.69M$33.28M$30.83M$32.42M$36.76M$41.77M$41.86M$35.06M$32.88M$28.93M$27.55M$30.98M
    Cash and equivalents$1.27M$1.05M$573.00K$1.29M$429.00K$4.11M$1.82M$1.41M$2.92M$2.36M$2.02M$1.72M
    Shareholder equity$16.75M$13.00M$13.16M$17.63M$13.48M$18.19M$15.16M$14.95M$15.17M$11.92M$4.95M$1.90M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$8.57M$1.97M-$2.01M-$1.65M$2.32M-$2.06M-$2.78M-$1.34M-$960.00K-$241.00K
    Capital expenditures$2.14M$4.56M$1.05M$2.82M$1.87M$878.00K$740.00K$160.00K$209.00K$165.00K
    Free cash flow-$10.71M-$2.59M-$3.06M-$4.47M$447.00K-$2.94M-$3.52M-$1.50M-$1.17M-$406.00K
    Investing cash flow-$2.14M-$4.56M-$1.05M-$2.82M-$1.87M-$878.00K-$740.00K-$160.00K-$72.00K-$165.00K
    Financing cash flow$10.59M$2.27M$2.59M$6.00M-$747.00K$2.70M$3.37M$892.00K$1.21M$910.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$6.72M$191.00K$1.52M$1.82M-$2.51M-$654.00K-$7.22M$2.19M$4.20M-$565.00K-$3.85M-$2.65M
    Capital expenditures$539.00K$469.00K$528.00K$450.00K$418.00K$1.41M$133.00K$2.59M$1.40M$477.00K$85.00K$199.00K
    Free cash flow$6.18M-$278.00K$989.00K$1.37M-$2.93M-$2.06M-$7.35M-$404.00K$2.80M-$1.04M-$3.94M-$2.85M
    Last 12 quarters

    Frequently Asked Questions About SLSN

    What is Solesence, Inc. Common Stock's annual revenue?

    Solesence, Inc. Common Stock reported revenue of $62.06M for the fiscal year ended Dec 31, 2025.

    How fast is Solesence, Inc. Common Stock's revenue growing?

    Revenue was up 18.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.5%.

    Is Solesence, Inc. Common Stock profitable?

    Yes. Solesence, Inc. Common Stock reported net income of $2.81M for the fiscal year ended Dec 31, 2025, with a net margin of 4.5%.

    How much free cash flow does SLSN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$8.57M minus capital expenditures of $2.14M produced free cash flow of -$10.71M.

    How much debt does Solesence, Inc. Common Stock have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $10.50M, short-term debt of $1.25M and cash and equivalents of $1.29M.